These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15179455)
41. Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures. Nave R Bioanalysis; 2010 Apr; 2(4):807-14. PubMed ID: 21083275 [TBL] [Abstract][Full Text] [Related]
43. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Van den Bosch JM; Westermann CJ; Aumann J; Edsbäcker S; Tönnesson M; Selroos O Biopharm Drug Dispos; 1993 Jul; 14(5):455-9. PubMed ID: 8218963 [TBL] [Abstract][Full Text] [Related]
44. The ideal steroid. Brattsand R Pulm Pharmacol Ther; 1999; 12(2):119-22. PubMed ID: 10373394 [No Abstract] [Full Text] [Related]
45. Inhalational Ciclesonide found beneficial in prevention of fat embolism syndrome and improvement of hypoxia in isolated skeletal trauma victims. Sen RK; Prakash S; Tripathy SK; Agarwal A; Sen IM Eur J Trauma Emerg Surg; 2017 Jun; 43(3):313-318. PubMed ID: 26781645 [TBL] [Abstract][Full Text] [Related]
46. Budesonide in children with asthma. Toogood JH Eur J Clin Pharmacol; 1988; 34(1):113-4. PubMed ID: 3360046 [No Abstract] [Full Text] [Related]
47. Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis. Hsu CK; Chao CM; Lai CC J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1129-1130. PubMed ID: 35995666 [No Abstract] [Full Text] [Related]
48. Comparison of cloprednol and prednisolone in chronic asthmatic patients. Ellul-Micallef R; Fenech FF; Parrott D Br J Clin Pharmacol; 1978 Jul; 6(1):91-3. PubMed ID: 352380 [No Abstract] [Full Text] [Related]
49. Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19. Chen CH; Wang CY; Lai CC JAMA Intern Med; 2022 May; 182(5):571-572. PubMed ID: 35311912 [No Abstract] [Full Text] [Related]
50. Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19-Reply. Clemency BM; Koster DJ; Blaiss MS JAMA Intern Med; 2022 May; 182(5):572. PubMed ID: 35311914 [No Abstract] [Full Text] [Related]
51. Drug approvals: '08 in review. Ciclesonide (Alvesco). Laustsen G; Carrillo F; Johnson J; Smith C Nurse Pract; 2009 Feb; 34(2):32-4. PubMed ID: 19155883 [No Abstract] [Full Text] [Related]
52. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. Johnson M J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 2):169-76. PubMed ID: 8568148 [No Abstract] [Full Text] [Related]
54. Should steroids be first choice for asthma? Strube G Thorax; 1998 Apr; 53(4):328. PubMed ID: 9741382 [No Abstract] [Full Text] [Related]
55. Anti-inflammatory treatment in clinical practice: a summary. Larsson K; Rosenhall L Clin Exp Allergy; 1996 Jun; 26 Suppl 4():18-9. PubMed ID: 8809434 [No Abstract] [Full Text] [Related]
56. Asthma "control". Anthonisen NR Can Respir J; 2004; 11(8):529-30. PubMed ID: 15611800 [No Abstract] [Full Text] [Related]
57. Steroids in acute exacerbation of asthma: how do we grade the evidence? Marik PE; Varon J Chest; 1999 Aug; 116(2):273-5. PubMed ID: 10453848 [No Abstract] [Full Text] [Related]
59. Molecule of the month. Ciclesonide. Drug News Perspect; 2004 Apr; 17(3):204-5. PubMed ID: 15179455 [No Abstract] [Full Text] [Related]
60. Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma. Bateman ED Expert Rev Respir Med; 2013 Aug; 7(4):339-48. PubMed ID: 23964625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]